Re: New Apabetalone Fabry Disease Publication
in response to
by
posted on
Apr 27, 2022 01:10PM
"From observation, what has been consistent through the years though, is trying to cheap out on the science side while paying market or higher on the management side."
& there's the fricking ELEPHANT in the room! He's happy, raping both companies IMO & in that 20 years of pillaging management has created ZERO Sharholder Value. It's so apparent what the issue is here & has been with this play. The main reason I can't stand to listen to him , always so hard working & excited but never has an ounce of that spilled onto the SH/Market.
Nothing to show for all this blabber,hardwork & excitment yet he & the BOD live like kings & continue to feed us bs in the way of forward looking statements.
Hanging in Hawaii majority of the time doing NOTHING as he continues to farm out most everything out.